Retatrutide

Retatrutide (LY-3437943) is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This investigational compound represents a new class of multi-receptor agonist peptides being studied for metabolic research applications.

Key Features:

• High purity (≥ 99.6%)
• White lyophilized powder
• Triple receptor activity (GIP/GLP-1/Glucagon)
• Novel research compound

Research Applications:

• Metabolic regulation studies
• Receptor binding and activation research
• Energy homeostasis studies
• Incretin pathway research